{"id":16290,"date":"2023-03-21T11:06:53","date_gmt":"2023-03-21T10:06:53","guid":{"rendered":"https:\/\/www.pharmaforum.be\/products\/cbd-phar-melatonine\/"},"modified":"2023-07-11T14:56:40","modified_gmt":"2023-07-11T12:56:40","slug":"cbd-phar-melatonine","status":"publish","type":"products","link":"https:\/\/www.pharmaforum.be\/fr\/products\/cbd-phar-melatonine\/","title":{"rendered":"CBD-PHAR + M\u00e9latonine"},"content":{"rendered":"<p>CBD-Phar Large spectre + M\u00e9latonine est le dernier n\u00e9 de la gamme CBD-Phar et combine les effets positifs du CBD avec ceux de la m\u00e9latonine.<br \/>\nLe CBD-Phar contient moins de 0,2 % de THC et n\u2019a donc aucun effet psychoactif. Par cons\u00e9quent, il ne rel\u00e8ve pas non plus de la l\u00e9gislation sur les stup\u00e9fiants et est donc l\u00e9gal en Belgique.<br \/>\nwww.cbd-phar.be<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CBD-Phar Large spectre + M\u00e9latonine est le dernier n\u00e9 de la gamme CBD-Phar et combine les effets positifs du CBD avec ceux de la m\u00e9latonine. Le CBD-Phar contient moins de 0,2 % de THC et n\u2019a donc aucun effet psychoactif. Par cons\u00e9quent, il ne rel\u00e8ve pas non plus de la l\u00e9gislation sur les stup\u00e9fiants et [&hellip;]<\/p>\n","protected":false},"featured_media":16292,"template":"","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_api_id":"186369","_exhibitors":["15840"],"footnotes":""},"tags":[],"edition":[451],"product-category":[275],"class_list":["post-16290","products","type-products","status-publish","has-post-thumbnail","hentry","edition-pharma-forum-2023","product-category-galerie-des-innovations"],"_links":{"self":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/products\/16290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/products"}],"about":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/types\/products"}],"version-history":[{"count":2,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/products\/16290\/revisions"}],"predecessor-version":[{"id":16714,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/products\/16290\/revisions\/16714"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/media\/16292"}],"wp:attachment":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/media?parent=16290"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/tags?post=16290"},{"taxonomy":"edition","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/edition?post=16290"},{"taxonomy":"product-category","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/product-category?post=16290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}